Habil Khorakiwala, chairman, Wockhardt Ltd addressed the media after the US health regulator said it did not find any issues with respect to data security and control measures at Chikalthana plant in a recent inspection.
Habil Khorakiwala, chairman, Wockhardt Ltd addressed the media after the US health regulator said it did not find any issues with respect to data security and control measures at Chikalthana plant in a recent inspection.
Khorakiwala said the company will respond to queries on Form 483 in next few months. The USFDA is expected to visit the remaining facilities soon.
Watch video for the entire press conference
Wockhardt stock price
On March 19, 2015, at 14:14 hrs Wockhardt was quoting at Rs 1943.50, up Rs 65.15, or 3.47 percent. The 52-week high of the share was Rs 1980.00 and the 52-week low was Rs 444.30.
The company's trailing 12-month (TTM) EPS was at Rs 33.45 per share as per the quarter ended December 2014. The stock's price-to-earnings (P/E) ratio was 58.1. The latest book value of the company is Rs 85.14 per share. At current value, the price-to-book value of the company is 22.83.
Anda sedang membaca artikel tentang
Expect US FDA to visit remaining facilities soon: Wockhardt
Dengan url
https://kesehatanda.blogspot.com/2015/03/expect-us-fda-to-visit-remaining.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Expect US FDA to visit remaining facilities soon: Wockhardt
namun jangan lupa untuk meletakkan link
Expect US FDA to visit remaining facilities soon: Wockhardt
sebagai sumbernya
0 komentar:
Posting Komentar